Cathleen Haase-Kohn

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Cancer Stem Cells

Radiation Therapy

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Cathleen Haase-Kohn, Markus Laube, Cornelius K Donat, Birgit Belter, Jens Pietzsch
CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells. Cells 11 (4) (2022)
Florian Brandt, Martin Ullrich, Verena Seifert, Cathleen Haase-Kohn, Susan Richter, Torsten Kniess, Jens Pietzsch, Markus Laube
Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells. Molecules (Basel, Switzerland) 27 (19) (2022)
Julia Aepler, Johanna Wodtke, Robert Wodtke, Cathleen Haase-Kohn, Reik Löser, Jens Pietzsch, Sandra Hauser
The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells. Cells 11 (8) (2022)
Markus Laube, Cemena Gassner, Christin Neuber, Robert Wodtke, Martin Ullrich, Cathleen Haase-Kohn, Reik Löser, Martin Köckerling, Klaus Kopka, Torsten Kniess, Evamarie Hey-Hawkins, Jens Pietzsch
Deuteration versus ethylation - strategies to improve the metabolic fate of an 18 F-labeled celecoxib derivative. RSC advances 10 (63) (2020)